Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Overall“
Suchtreffer
Begriffe & Kennungen
Brilique · 4.8 · Table 3 – Analysis of overall bleeding events, Kaplan-Meier estimates at 36 months (PEGASUS)
Eintrag öffnenBrilique · 4.8 · Table 3 – Analysis of overall bleeding events, Kaplan-Meier estimates at 36 months (PEGASUS)
Eintrag öffnenByooviz · 4.8 · In the wet AMD phase III studies, the overall frequency of non-ocular haemorrhages, an adverse event potential
Eintrag öffnenByooviz · 4.8 · In the wet AMD phase III studies, the overall frequency of non-ocular haemorrhages, an adverse event potential
Eintrag öffnenCapecitabine Accord · 4.8 · The overall safety profile of capecitabine is based on data from over 3,000 patients treated with capecitabine
Eintrag öffnenCapecitabine Medac · 4.8 · The overall safety profile of capecitabine is based on data from over 3,000 patients treated with capecitabine
Eintrag öffnenCapecitabine Teva · 4.8 · The overall safety profile of capecitabine is based on data from over 3000 patients treated with capecitabine
Eintrag öffnenCerezyme · 4.8 · Symptoms suggestive of hypersensitivity have been noted, overall, in approximately 3% of the patients. Onset o
Eintrag öffnenCinryze · 4.8 · Overall, the safety and tolerability of Cinryze are similar in children, adolescents and adults. For safety wi
Eintrag öffnenClopidogrel BGR (previously Zylagren) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel BGR (previously Zylagren) · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel BGR (previously Zylagren) · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel HCS · 4.8 · 7 In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both g
Eintrag öffnenClopidogrel HCS · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel HCS · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel Krka · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Krka · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnen